The board of directors of Shanghai Pharmaceuticals Holding Co. Ltd. announced that the principal place of business of the Company in Hong Kong has been changed to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong with effect from 20 February 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.02 CNY | -0.28% | +0.56% | +7.71% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.71% | 8.31B | |
+17.42% | 71.72B | |
-3.33% | 24.29B | |
-19.61% | 8.22B | |
+1.47% | 8.16B | |
+5.56% | 4.76B | |
+15.41% | 4.31B | |
-0.87% | 4.1B | |
+23.20% | 3.78B | |
+6.89% | 3.36B |
- Stock Market
- Equities
- 601607 Stock
- News Shanghai Pharmaceuticals Holding Co., Ltd
- Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong